医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

The New Era Biotechnology deepens cooperation between China and Belarus in the Great Stone China Belarus Industrial Park (CBIP)

2021年11月15日 PM10:32
このエントリーをはてなブックマークに追加


 

MINSK, Belarus

As an enterprise in CBIP, the New Era Biotechnology Co., Ltd. participated in the fourth edition of the China International Import Expo (CIIE) which opened in Shanghai on November 5, 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211115005814/en/

Unveiling Ceremony was held by New Era Biotechnology Co., Ltd. in CBIP (Photo: Business Wire)

Unveiling Ceremony was held by New Era Biotechnology Co., Ltd. in CBIP (Photo: Business Wire)

Located in Minsk, capital of the Republic of Belarus and a major hub of the Silk Road Economic Belt, CBIP is helping boost cooperation between China and Belarus. In recent years, China and Belarus have carried out fruitful exchanges and cooperation in the field of traditional medicine, and CBIP lately saw new achievements in facilitating cooperation between the two countries in fighting Covid-19 and developing Chinese pure herbal medicine. With the support from the governments of the two countries, CBIP has played an increasing role in promoting regional cooperation and economic and trade exchanges between the two countries, and also serves as a platform for international production capacity cooperation and science and technology innovation along the Belt and Road. Currently, it is home to 80 enterprises.

In March 2021, the Jintai Institute of Culture and Economics of China, led by Dr. Cai Chuanqing, founded the New Era Biotechnology Co., Ltd. in CBIP. It is the 69th company in CBIP, and the first engaged in Chinese pure herbal medicine in it. Belarus’ unique folk medicine tradition and rich medicinal plant resources provide broad prospects for the two countries to cooperate in traditional medicine.

In June 2021, Belarus issued a presidential decree on improving the business environment of CBIP. The presidential decree allows enterprises in CBIP to provide medical services using traditional Chinese herbal therapies without mandatory registration with and license from Belarusian authorities.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005814/en/

CONTACT

Ms. Xing Nizhen

Tel: 0037533-6249999

E-mail: novaerabiotech@mail.ru

TimeLine:

同じカテゴリーの記事 

  • Verastem Oncology Announces First Patient Dosed with GFH375/VS-7375, a KRAS G12D (ON/OFF) Inhibitor, in a Phase 1/2 Trial in China as Part of Collaboration with GenFleet Therapeutics
  • パース・バイオサイエンシズ、認定サービスプロバイダープログラムを開始
  • Parse Biosciences推出认证服务提供商计划
  • ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders’ Voices Expressed at the AGM
  • Sunbird Bio to Present Data from Study Evaluating Tau Blood-Based Biomarkers at the Alzheimer’s Association International Conference® 2024 (AAIC®)